Back to results
CompletedPhase 2

A Study to Evaluate the Impact of MABT5102A on Brain Amyloid Load and Related Biomarkers in Patients With Mild to Moderate Alzheimer's Disease

NCT01397578

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Banner Alzheimer's Institute

Phoenix, Arizona, United States

+28 additional locations

View on ClinicalTrials.gov